6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: A randomised, double-blind, placebo-controlled trial

The Lancet

Volumn 377, Issue 9777, 2011, Pages 1588-1598

  Samandari, Taraz ^a,c   Agizew, Tefera B ^a   Nyirenda, Samba ^a   Tedla, Zegabriel ^a   Sibanda, Thabisa ^a   Shang, Nong ^c   Mosimaneotsile, Barudi ^a   Motsamai, Oaitse I ^b   Bozeman, Lorna ^c   Davis, Margarett K ^a   Talbot, Elizabeth A ^a,c   Moeti, Themba L ^b   Moffat, Howard J ^b   Kilmarx, Peter H ^d   Castro, Kenneth G ^c   Wells, Charles D ^c  

^a Botswana USA (BOTUSA)   (Botswana)

^b Department of HIV AIDS Prevention and Care   (Botswana)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRIDOXINE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BOTSWANA; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFECT; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OPEN STUDY; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THORAX RADIOGRAPHY; TREATMENT DURATION; TUBERCULIN TEST; TUBERCULOSIS;

EID: 79955694277     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60204-3     Document Type: Article

References (41)

1. A Reid, F Scano, H Getahun Towards universal access to HIV prevention, treatment, care and support: the role of tuberculosis/HIV collaboration Lancet Infect Dis 6 2006 483 495 (Pubitemid 44109811)
2. C Akolo, I Adetifa, S Shepperd, J Volmink Treatment of latent tuberculosis infection in HIV infected persons Cochrane Database Syst Rev 1 2010 CD000171.
3. Anon Preventive therapy against tuberculosis in people living with HIV. Policy statement Wkly Epidemiol Record 74 1999 385 398
4. B Mosimaneotsile, EA Talbot, TL Moeti Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana Lancet 362 2003 1551 1552 (Pubitemid 37410196)
5. SD Lawn, L Myer, D Edwards Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa AIDS 23 2009 1717 1725
6. JE Golub, V Saraceni, SC Cavalcante The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil AIDS 21 2007 1441 1448 (Pubitemid 46988004)
7. JE Golub, P Pronyk, L Mohapi Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort AIDS 23 2009 631 636
8. B Ojikutu, AT Makadzange, T Gaolathe Scaling up ART treatment capacity: lessons learned from South Africa, Zimbabwe, and Botswana Curr Infect Dis Rep 10 2008 69 73 (Pubitemid 351419364)
9. A Mwinga, M Hosp, P Godfrey-Faussett Twice weekly tuberculosis preventive therapy in HIV infection in Zambia AIDS 12 1998 2447 2457 (Pubitemid 28558603)
10. CC Whalen, JL Johnson, A Okwera A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration N Engl J Med 337 1997 801 808 (Pubitemid 27391629)
11. MA Quigley, A Mwinga, M Hosp Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults AIDS 15 2001 215 222 (Pubitemid 32142297)
12. JL Johnson, A Okwera, DL Hom Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults AIDS 15 2001 2137 2147 (Pubitemid 33101821)
13. S Verver, RM Warren, N Beyers Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis Am J Respir Crit Care Med 171 2005 1430 1435 (Pubitemid 40800517)
14. S Charalambous, AD Grant, V Moloi Contribution of reinfection to recurrent tuberculosis in South African gold miners Int J Tuberc Lung Dis 12 2008 942 948
15. CF Gilks, P Godfrey-Faussett, BI Batchelor Recent transmission of tuberculosis in a cohort of HIV-1-infected female sex workers in Nairobi, Kenya AIDS 11 1997 911 918 (Pubitemid 27226415)
16. S Lockman, JD Sheppard, CR Braden Molecular and conventional epidemiology of Mycobacterium tuberculosis in Botswana: a population-based prospective study of 301 pulmonary tuberculosis patients J Clin Microbiol 39 2001 1042 1047 (Pubitemid 32209719)
17. PJ Easterbrook, A Gibson, S Murad High rates of clustering of strains causing tuberculosis in Harare, Zimbabwe: a molecular epidemiological study J Clin Microbiol 42 2004 4536 4544 (Pubitemid 39362368)
18. JR Glynn, AC Crampin, MD Yates The importance of recent infection with Mycobacterium tuberculosis in an area with high HIV prevalence: a long-term molecular epidemiological study in Northern Malawi J Infect Dis 192 2005 480 487 (Pubitemid 41023127)
19. B Mosimaneotsile, A Mathoma, B Chengeta Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a Botswana experience, 2004-2006 JAIDS 54 2010 71 77
20. US National Institutes of Health Cancer Therapy Evaluation Program. Common terminology criteria for adverse events, version 3.0 http://ctep.cancer. gov/protocolDevelopment/electronic-applications/ctc.htmctc-30 (accessed Feb 7, 2011).
21. D Wilkinson, SB Squire, P Garner Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials BMJ 317 1998 625 629 (Pubitemid 28403484)
22. J Chirenda, H Menzies, G Moalosi The trend of resistance to anti-tuberculosis drugs in Botswana: results from the 4th national anti-TB drug resistance survey Int J Tuberc Lung Dis 13 suppl 1 2009 S3
23. Z Tedla, S Nyirenda, C Peeler Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in HIV-infected adults Am J Respir Crit Care Med 182 2010 278 285
24. Martinson N, Barnes G, Msandiwa R, et al. Novel regimens for treating latent TB in HIV-infected adults in South Africa: a randomized clinical trial. 16th Conference on Retroviruses and Opportunistic Infections; Montreal, QC, Canada; Feb 8-11, 2009. 36bLB.
25. A Rivero, L Lopez-Cortes, R Castillo Randomised trial of three regimens to prevent tuberculosis in HIV-infected patients with anergy Enferm Infecc Microbiol Clin 21 2003 287 292 (Pubitemid 36869935)
26. J Pape, S Jean, J Ho Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection Lancet 342 1993 268 271
27. FM Gordin, JP Matts, C Miller A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS N Engl J Med 337 1997 315 320 (Pubitemid 27318993)
28. AM Elliott, WS Hodsdon, J Kyosiimire Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study Trans R Soc Trop Med Hyg 98 2004 660 670 (Pubitemid 40029118)
29. VA Boussiotis, EY Tsai, EJ Yunis IL-10-producing T cells suppress immune responses in anergic tuberculosis patients J Clin Invest 105 2000 1317 1325 (Pubitemid 30266085)
30. JC Delgado, EY Tsai, S Thim Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia Proc Natl Acad Sci USA 99 2002 7576 7581 (Pubitemid 34568733)
31. A Tsicopoulos, Q Hamid, V Varney Preferential messenger RNA expression of Th1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human J Immunol 148 1992 2058 2061
32. HL Rieder Preventing latent tuberculosis among HIV-infected patients: efficacious and effective, yet inefficient? Clin Infect Dis 44 2007 103 104 (Pubitemid 44968993)
33. F Gordin, RE Chaisson, JP Matts Rifampin and pyrazinamide vs isonaizid for prevention of tuberculosis in HIV-infected persons: an international randomized trial JAMA 283 2000 1445 1450 (Pubitemid 30151823)
34. M Badri, D Wilson, R Wood Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study Lancet 359 2002 2059 2064 (Pubitemid 34680968)
35. G Santoro-Lopes, AM de Pinho, LH Harrison Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy Clin Infect Dis 34 2002 543 546 (Pubitemid 34112278)
36. A Miranda, M Morgan, L Jamal Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001 PLos One 2 2007 e826
37. SD Lawn, L Myer, L-G Bekker Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control AIDS 20 2006 1605 1612 (Pubitemid 44162402)
38. W Were, D Moore, P Ekwaru A simple screening tool for active tuberculosis in HIV-infected adults receiving antiretroviral treatment in Uganda Int J Tuberc Lung Dis 13 2009 47 53
39. D Moore, C Liechty, P Ekwaru Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda AIDS 21 2007 713 719 (Pubitemid 46568628)
40. S Charalambous, AD Grant, C Innes Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme AIDS 24 suppl 5 2010 S5 S13
41. T Harrington, L Managan, J Jereb Severe isoniazid-associated liver injuries among persons being treated for latent tuberculosis infection-United States, 2004-2008 MMWR Morb Mortal Wkly Rep 59 2010 224 229